Citation Impact
Citing Papers
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
2016
Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction
2001
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Leukotriene-receptor antagonists
1999
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
2005
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
2008
Apoptosis in the nervous system
2000 StandoutNature
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
2016
Phagocytes and oxidative stress
2000
Brain Hydroxyl Radical Generation in Acute Experimental Head Injury
1993
Rheumatoid arthritis
2016 Standout
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
2016
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
2003
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
2015
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis
2015
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
Interventions for enhancing medication adherence
2005
Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children
2006
Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
1997 StandoutNobel
Endometriosis
2009 Standout
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
2015
Apoptosis by Death Factor
1997 Standout
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast
2006
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
2007
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
1999
Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study
2004
Simulations of electron transfer in the NADPH-bound catalase from Proteus mirabilis PR
1995
Pharmacological modulation of the leukotriene pathway in allergic airway disease
2007
Effect of long‐acting β2 agonists on exacerbation rates of asthma in children
2003
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
2016
Cell Death
2004 Standout
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma
2001
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
1999
Deciphering key features in protein structures with the new ENDscript server
2014 Standout
Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis
2001
Manganic Porphyrins Possess Catalase Activity and Protect Endothelial Cells against Hydrogen Peroxide-Mediated Injury
1997
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
The importance of selenium to human health
2000 Standout
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
2003
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
1993 Standout
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Asthma
2001 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial
2001
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
2014
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
1996 Standout
Rheumatoid arthritis
2010 Standout
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties
2004
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma
1998
Asthma Therapy with Agents Preventing Leukotriene Synthesis or Action
1999
Programmed Cell Death in Animal Development
1997 Standout
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
2015
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
1999 StandoutNature
Biomarkers in Heart Failure
2008 Standout
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
2016
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
2000
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
2017
Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis
2016
Oxidative damage and mitochondrial decay in aging.
1994 Standout
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain
2003 StandoutNobel
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
H 2 O 2 , a Necessary Evil for Cell Signaling
2006 StandoutScience
Lymphocyte Homing and Homeostasis
1996 StandoutScience
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study
2005
cDNA cloning, characterization, and tissue-specific expression of human xanthine dehydrogenase/xanthine oxidase.
1993
Interventions for enhancing medication adherence
2008 Standout
Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy
2001
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
2017
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
2001
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
1995 StandoutScience
Interventions for enhancing medication adherence
2014 Standout
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
The Mononuclear Molybdenum Enzymes
1996 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Superoxide Ion: Generation and Chemical Implications
2016 Standout
The Mononuclear Molybdenum Enzymes
2014 Standout
Mortality Risk in Selenium-Deficient HIV-Positive Children
1999
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
2008
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Methotrexate as a steroid sparing agent for asthma in adults
1998
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Idiopathic Pulmonary Fibrosis
2018 Standout
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
2016
Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia
1997
Works of Jonathan A. Leff being referenced
Generation of superoxide anion by brain endothelial cell xanthine oxidase
1991
Effect of low-dose methotrexate on the disposition of glucocorticoids and theophylline
1991
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction
1999
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
2015
Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction
1998
Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection
1992
Inactivation of xanthine oxidase by hydrogen peroxide involves site-directed hydroxyl radical formation
1991
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
2005
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
2013
Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females
1996
Disparate Antioxidant Enzyme Activities in Cultured Human Cutaneous Fibroblasts, Keratinocytes, and Melanocytes
1991
Increased serum catalase activity in rats subjected to thermal skin injury
1993
All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials
2014
Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
2006
Reply
2002
Interleukin-1 induced lung neutrophil accumulation and oxygen metabolite mediated lung leak in rats
1993
Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3
2003
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
2005
Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy
2001
Autoimmune and Inflammatory Diseases
1994
Comprehensive assessment of the long‐term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
2014
Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.
2004
Comparison of oral montelukast and inhaled cromolyn with respect to preference, satisfaction, and adherence: a multicenter, randomized, open-label, crossover study in children with mild to moderate persistent asthma
2000
Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction
1999